YU10503A - Kompleksi koji sadrže perfluoralkile sa polarnim ostacima, postupci za njihovo dobijanje i njihova primena - Google Patents

Kompleksi koji sadrže perfluoralkile sa polarnim ostacima, postupci za njihovo dobijanje i njihova primena

Info

Publication number
YU10503A
YU10503A YU10503A YUP10503A YU10503A YU 10503 A YU10503 A YU 10503A YU 10503 A YU10503 A YU 10503A YU P10503 A YUP10503 A YU P10503A YU 10503 A YU10503 A YU 10503A
Authority
YU
Yugoslavia
Prior art keywords
complexes containing
production
polar radicals
polar
perfluoralkyl
Prior art date
Application number
YU10503A
Other languages
English (en)
Inventor
Johannes Platzek
Peter Mareski
Ulrich Niedballa
Bernd Raduchel
Hanns-Joachim Weinmann
Bernd Misselwitz
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of YU10503A publication Critical patent/YU10503A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F19/00—Metal compounds according to more than one of main groups C07F1/00 - C07F17/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Kompleksi koji sadrže perfluoralkile s polarnim ostacima opšte formule I u kojoj R znači polarni ostatak R1 perfluorisani ugljenični lanac, K je metalni kompleks, a Z predstavlja linker-grupu, su podesni za intravenoznu limfografiju, dijagnostiku tumora i vizuelizaciju infarkta i nekroze.[The invention relates to complexes containing perfluoroalkyl with polar radicals of general formula (I), wherein R represents the polar radical, Rf is a perfluorated carbon chain, K is a metal complex and Z is a linker group. The inventive complexes are suitable for intravenous lymphography, tumor diagnosis and infarct and necrosis imaging.
YU10503A 2000-08-11 2001-07-23 Kompleksi koji sadrže perfluoralkile sa polarnim ostacima, postupci za njihovo dobijanje i njihova primena YU10503A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10040858A DE10040858C2 (de) 2000-08-11 2000-08-11 Perfluoralkylhaltige Komplexe mit polaren Resten, Verfahren zu deren Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
YU10503A true YU10503A (sh) 2006-08-17

Family

ID=7653176

Family Applications (1)

Application Number Title Priority Date Filing Date
YU10503A YU10503A (sh) 2000-08-11 2001-07-23 Kompleksi koji sadrže perfluoralkile sa polarnim ostacima, postupci za njihovo dobijanje i njihova primena

Country Status (30)

Country Link
EP (1) EP1307237B9 (sh)
JP (1) JP2004506026A (sh)
KR (2) KR20030022381A (sh)
CN (1) CN1468113A (sh)
AR (1) AR035342A1 (sh)
AT (1) ATE359093T1 (sh)
AU (2) AU7977701A (sh)
BG (1) BG107541A (sh)
BR (1) BR0113187A (sh)
CA (1) CA2419259A1 (sh)
CZ (1) CZ2003341A3 (sh)
DE (2) DE10040858C2 (sh)
DK (1) DK1307237T3 (sh)
EE (1) EE200300060A (sh)
ES (1) ES2284671T3 (sh)
HR (1) HRP20030171A2 (sh)
HU (1) HUP0300769A3 (sh)
IL (1) IL154329A0 (sh)
MX (1) MXPA03001286A (sh)
NO (1) NO20030649L (sh)
NZ (1) NZ524080A (sh)
PL (1) PL365367A1 (sh)
PT (1) PT1307237E (sh)
RU (1) RU2289579C2 (sh)
SK (1) SK286239B6 (sh)
UA (1) UA74004C2 (sh)
UY (1) UY26873A1 (sh)
WO (1) WO2002013875A2 (sh)
YU (1) YU10503A (sh)
ZA (1) ZA200301947B (sh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7344704B2 (en) 2002-07-10 2008-03-18 Schering Ag Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of intravascular thrombi
DE10231799B4 (de) * 2002-07-10 2006-10-05 Schering Ag Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Intravasalen Thromben
EP1904462A2 (de) * 2005-07-15 2008-04-02 Bayer Schering Pharma Aktiengesellschaft Perfluoralkylhaltige komplexe, verfahren zu deren herstellung, sowie deren verwendung
DE102005033902B3 (de) * 2005-07-15 2007-04-05 Schering Ag Perfluoralkylhaltige Komplexe, Verfahren zu deren Herstellung, sowie deren Verwendung und diese enthaltende pharmazeutische Mittel
DE102005033903B4 (de) * 2005-07-15 2007-08-09 Bayer Schering Pharma Ag Perfluoralkylhaltige Komplexe, Verfahren zu deren Herstellung, sowie deren Verwendung und diese enthaltende pharmazeutische Mittel
DE102006049821A1 (de) 2006-10-18 2008-04-24 Bayer Schering Pharma Aktiengesellschaft Metallchelate mit perfluoriertem PEG-Rest, Verfahren zu deren Herstellung, sowie deren Verwendung
DE102007015598A1 (de) * 2007-03-29 2008-10-02 Heinrich-Heine-Universität Düsseldorf Verwendung von fluorhaltigen Verbindungen zu Diagnosezwecken mit Hilfe bildgebender Verfahren
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
US10975060B2 (en) 2016-11-28 2021-04-13 Bayer Pharma Aktiengesellschaft High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging
RU2681319C1 (ru) * 2017-10-27 2019-03-06 Федеральное государственное бюджетное образовательное учреждение высшего образования "Российский экономический университет имени Г.В. Плеханова" (ФГБОУ ВО "РЭУ им. Г.В. Плеханова") Ультраволокнистый биополимерный материал с бактерицидным эффектом
CN113164628A (zh) 2018-11-23 2021-07-23 拜耳股份有限公司 造影介质制剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4317588C2 (de) * 1993-05-24 1998-04-16 Schering Ag Fluorhaltige makrocyclische Metallkomplexe, Verfahren zu ihrer Herstellung, sowie ihre Verwendung
DE19603033A1 (de) * 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19608278A1 (de) * 1996-02-23 1997-08-28 Schering Ag Pharmazeutische Mittel enthaltend perfluoralkylhaltige Metallkomplexe, und ihre Verwendung in der Tumortherapie und interventioniellen Radiologie
DE19729013A1 (de) * 1997-07-03 1999-02-04 Schering Ag Oligomere, perfluoralkylhaltige Verbindungen, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19744004C1 (de) * 1997-09-26 1999-07-22 Schering Ag Lipophile Metall-Komplexe für Nekrose und Infarkt-Imaging

Also Published As

Publication number Publication date
BR0113187A (pt) 2003-07-01
MXPA03001286A (es) 2004-04-20
KR20080027397A (ko) 2008-03-26
WO2002013875A2 (de) 2002-02-21
RU2289579C2 (ru) 2006-12-20
PT1307237E (pt) 2007-07-02
CN1468113A (zh) 2004-01-14
AU7977701A (en) 2002-02-25
CA2419259A1 (en) 2002-02-21
NO20030649L (no) 2003-04-11
ZA200301947B (en) 2004-06-25
HUP0300769A2 (hu) 2003-09-29
DK1307237T3 (da) 2007-07-02
SK286239B6 (sk) 2008-06-06
BG107541A (bg) 2004-01-30
HUP0300769A3 (en) 2009-03-02
WO2002013875A3 (de) 2002-08-22
DE50112336D1 (de) 2007-05-24
UY26873A1 (es) 2002-03-22
ES2284671T3 (es) 2007-11-16
PL365367A1 (en) 2004-12-27
EP1307237B1 (de) 2007-04-11
UA74004C2 (en) 2005-10-17
EE200300060A (et) 2004-12-15
EP1307237A2 (de) 2003-05-07
DE10040858C2 (de) 2003-12-18
SK1552003A3 (en) 2003-09-11
HRP20030171A2 (en) 2004-06-30
AU2001279777B2 (en) 2006-08-31
AR035342A1 (es) 2004-05-12
ATE359093T1 (de) 2007-05-15
KR20030022381A (ko) 2003-03-15
NZ524080A (en) 2005-10-28
IL154329A0 (en) 2003-09-17
NO20030649D0 (no) 2003-02-10
CZ2003341A3 (cs) 2003-05-14
JP2004506026A (ja) 2004-02-26
EP1307237B9 (de) 2008-01-09
DE10040858A1 (de) 2002-03-28

Similar Documents

Publication Publication Date Title
YU10503A (sh) Kompleksi koji sadrže perfluoralkile sa polarnim ostacima, postupci za njihovo dobijanje i njihova primena
WO2004106390A3 (en) Polymerization and oligomerization catalyst with tridentate or tetradentate ligand
MX9805499A (es) Compuestos de azacicloheptano y diazacicloheptano y ciclooctano sustituidos y su uso.
HUP0400235A2 (hu) Eljárás nemciklusos olefinek telomerizálására
MXPA03011197A (es) Benzoilsufonamidas y sulfonilbenzamidinas que se usan como agentes antitumorales.
AP2003002853A0 (en) Heterocyclic inhibitors of ERK2 and uses thereof
MXPA04001088A (es) Derivados de pirazol como inhibidores de cinasa y uso de los mismos.
MXPA04004498A (es) Derivados de n-adamantilmetil e intermediarios como composiciones farmaceuticas y procesos para su preparacion.
ZA985895B (en) Oligomeric compounds that contain perfluoralkyl process for their production and their use in nmr diagnosis
MXPA04004940A (es) Proceso para preparar 3,3??,5,5??,6,6??-hexaalquil-2,2??-bifenoles, 3,3??,4,4??,5,5??-hexaalquil-2,2??-bifenoles y 3,3??,4,4??,5,5??,6,6??-octaalquil-2,2??-bifenoles.
MX9708848A (es) Metodo y aparato para la produccion de carburo ferrico.
WO2004035631A3 (en) Metal nanoparticle thermoset and carbon compositions from mixtures of metallocene-aromatic-acetylene compounds
PL363990A1 (en) Arylsulfonamides as antiviral agents
DE602005020133D1 (de) Übergangsmetallverbindungen für die olefinpolymerisation und -oligomerisation
ATE323109T1 (de) Verwendung von heparinoid-derivaten zur behandlung und diagnose von mit heparinoiden behandelbaren erkrankungen
DE60224225D1 (de) AZO Verbindung
BR0113192A (pt) Complexos contendo perfluoralquila com radicais de açúcar, processos para a sua preparação e sua aplicação
TW200734294A (en) Polyarylene compound and process for producing the same
HUP9800649A2 (hu) Benzil-oxi-csoporttal helyettesített, kondenzált N-heterociklusos vegyületek, eljárás előállításukra és alkalmazásuk bradikinin receptorantagonistaként
DE60100252D1 (de) Verfahren zur herstellung von hex-1-en
MXPA04001005A (es) Metodo para controlar la precipitacion de asfalteno en un fluido.
MY134966A (en) Alkaline earth metal complexes and their use
ATE220680T1 (de) Taxane derivate, ihre herstellung und zusammensetzungen die sie enthalten
EP1568697A4 (en) 1,3-BENZOTHIAZINONE DERIVATIVES, THEIR MANUFACTURING METHOD AND USE
MXPA04000310A (es) Procedimiento para la preparacion de 2,4-didesoxihexosas y 2,4,6-tridesoxihexosas.